var data={"title":"Pouchitis: Epidemiology, clinical manifestations, and diagnosis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Pouchitis: Epidemiology, clinical manifestations, and diagnosis</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Bo Shen, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Paul Rutgeerts, MD, PhD, FRCP</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Kristen M Robson, MD, MBA, FACG</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jan 05, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pouchitis is the most frequently observed long-term complication of ileal pouch-anal anastomosis or a continent ileostomy (ie, Koch pouch). This topic will review the epidemiology, pathogenesis, clinical manifestations, and diagnosis of pouchitis. The management of pouchitis is discussed in detail, separately. (See <a href=\"topic.htm?path=pouchitis-management\" class=\"medical medical_review\">&quot;Pouchitis: Management&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1335092930\"><span class=\"h1\">DEFINITION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pouchitis is an inflammatory condition of the ileal pouch reservoir of an ileal pouch-anal anastomosis.</p><p class=\"headingAnchor\" id=\"H1335092780\"><span class=\"h2\">Classification</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pouchitis has been classified as follows [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Based on the duration of symptoms into acute (&le;4 weeks) versus chronic (&gt;4 weeks).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Based on response to antibiotics into antibiotic-responsive versus antibiotic-dependent (ie, requiring ongoing antibiotic therapy to keep disease in remission) versus antibiotic-refractory (ie, not responding to a standard course of antibiotic therapy).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Based on the frequency of flares into infrequent pouchitis (less than three episodes per year) versus relapsing pouchitis (three or more episodes per year).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Based on the disease extent into pouchitis versus pouch concurrent with prepouch <span class=\"nowrap\">ileitis/enteritis</span>.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Based on the etiology into idiopathic versus secondary. Secondary causes are further classified as follows:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Pathogen-associated (eg, cytomegalovirus, <em>Clostridium difficile,</em> <em>Clostridium perfringens</em>).</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Luminal or vascular factor-associated (eg, nonsteroidal anti-inflammatory drug, ischemia, fecal diversion, postobstructive from an outlet stricture).</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Autoimmune-associated (eg, IgG4-associated, primary sclerosing cholangitis-associated).</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Concurrent inflammatory or structural pouch disorders (eg, Crohn disease, cuffitis, pouch anastomotic sinus, pouch fistula, pouch prolapse, twisted pouch).</p><p/><p>These categories are not mutually exclusive. As an example, relapsing pouchitis may be considered a form of chronic pouchitis, even if the symptoms do not last for four weeks on therapy. Terminology combining the above features has also been used to characterize pouchitis (eg, chronic antibiotic-refractory pouchitis).</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Among patients who have undergone an ileal pouch-anal anastomosis (IPAA), the reported incidence of pouchitis ranges from 23 to 59 percent [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/2-14\" class=\"abstract_t\">2-14</a>]. Patients who have undergone an IPAA for ulcerative colitis have a higher incidence of pouchitis as compared with patients with familial adenomatous polyposis [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/2,15\" class=\"abstract_t\">2,15</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-familial-adenomatous-polyposis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of familial adenomatous polyposis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pathogenesis of pouchitis is unclear, but it is hypothesized to result from an abnormal immune response to altered luminal <span class=\"nowrap\">and/or</span> mucosal bacteria in genetically susceptible hosts. Pouchitis is not an isolated disease entity. Instead, it likely represents a disease spectrum ranging from acute antibiotic-responsive pouchitis to chronic antibiotic-refractory pouchitis (CARP). These disease phenotypes may reflect the same disease process at different stages or various disease processes with different etiopathogenetic pathways or cascades.</p><p class=\"headingAnchor\" id=\"H525290177\"><span class=\"h2\">Genetic factors</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pouchitis almost exclusively occurs in patients with restorative proctocolectomy with underlying inflammatory bowel disease (IBD) and rarely in those with familial adenomatous polyposis (FAP), suggesting the contribution of genetic <span class=\"nowrap\">and/systemic</span> factors to its pathogenesis. Immunogenetic studies have demonstrated that genetic polymorphisms such as those of interleukin (IL)-1 receptor antagonist, <span class=\"nowrap\">NOD2/CARD15,</span> or a combined carriership of TLR9-1237C and CD14-260T alleles are associated with an increased risk for chronic pouchitis [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/16-20\" class=\"abstract_t\">16-20</a>]. Patients with mutations of <span class=\"nowrap\">NOD2/CARD15</span> and TNFSF15 have been shown to have a higher risk for severe pouchitis [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/21\" class=\"abstract_t\">21</a>]. In addition, lower levels of expression of transcripts of genes related to xenobiotic efflux, such as <em>ABCB1</em>, have been found in pouchitis and Crohn disease-like conditions of the pouch, suggesting a role of barrier dysfunction in inflammation of the pouch [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/22\" class=\"abstract_t\">22</a>].</p><p class=\"headingAnchor\" id=\"H525290250\"><span class=\"h2\">Changes in gut microbiota</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although the phylogenetic composition of the fecal microbiota community is stable in healthy individuals, the construction of an ileal pouch promotes fecal stasis with bacterial overload and mucosal adaptive changes from small bowel mucosa to colon-like mucosa (ie, colonic metaplasia) of the pouch body and inflammation (<a href=\"image.htm?imageKey=GAST%2F93165\" class=\"graphic graphic_picture graphicRef93165 \">picture 1</a>) [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/23\" class=\"abstract_t\">23</a>].</p><p>The colon-like mucosa also creates a suitable environment for harboring colonic microbiota. For example, colonic metaplasia in the pouch predisposes to growth of sulfate-reducing bacteria that produce hydrogen sulfide, which in high concentrations is toxic to colonocytes [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/24\" class=\"abstract_t\">24</a>]. A gradual shift from an ileum-like to a colon-like bacterial community (including nonculturable bacteria such as <em>Clostridium coccoides</em> strains) occurs in the ileal pouch after colectomy [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/25\" class=\"abstract_t\">25</a>]. While no individual family, genus, or species has been consistently shown to be related to pouchitis, potential bacterial species that have been implicated in pouch inflammation include Lachnospiraceae, <em>Incertae Sedis XIV</em>, and <em>Clostridial </em>cluster IV [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/24,26-28\" class=\"abstract_t\">24,26-28</a>]. Studies have also suggested that Bacteriodaceae<em> </em>spp and Clostridiaceae<em> </em>spp may be related to pouch inflammation, while Enterococcaceae<em> </em>spp may play a role in maintaining immune homeostasis in the pouch mucosa [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/29\" class=\"abstract_t\">29</a>]. Another study found increased proportions of the Fusobacteriaceae family and decreased <em>Faecalibacterium</em> in patients with pouchitis [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/30\" class=\"abstract_t\">30</a>].</p><p>The microbiome and host transcriptome during pouchitis are affected by biopsy location and the presence of the inflammation [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/31\" class=\"abstract_t\">31</a>] as well as the use of antibiotics [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/30,31\" class=\"abstract_t\">30,31</a>] or fecal microbiota transplantation [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/31\" class=\"abstract_t\">31</a>]. In contrast, immunomodulator or anti-tumor necrosis factor (TNF) therapy appears to have only a minimum impact on microbiota of the pouch [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/30\" class=\"abstract_t\">30</a>].</p><p>In a subset of patients, pouchitis has been associated with infection with <em>C. difficile</em> [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/32-34\" class=\"abstract_t\">32-34</a>]. <em>C. difficile </em>pouchitis is an increasing problem in patients with ileal pouch-anal anastomosis, which may be due to repeated or chronic exposure to antibiotics [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/32,34\" class=\"abstract_t\">32,34</a>]. Other pathogenic microbes associated with episode of active pouchitis include <em>C. perfringens,</em><sup> </sup><em>Campylobacter </em>spp, Group D<em> </em>streptococci<em> </em>(<em>Enterococcus </em>spp), hemolytic strains of <em>E. coli</em>, <em>Histoplasma capsulatum</em>, and cytomegalovirus [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/35-42\" class=\"abstract_t\">35-42</a>].</p><p class=\"headingAnchor\" id=\"H525290635\"><span class=\"h2\">Abnormal mucosal immunity</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pouchitis has also been associated with an alteration in both innate and adaptive mucosal immunity [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/43-49\" class=\"abstract_t\">43-49</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fecal stasis with microbial overload in the ileal pouch reservoir can cause adaptive morphological alteration in the pouch mucosa, resulting in colonic metaplasia [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/50\" class=\"abstract_t\">50</a>]. Altered mucin glycoproteins may be more susceptible to enzymatic degradation by microbiota, leading to the breach of mucosal barrier function and subsequent pouchitis [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/51\" class=\"abstract_t\">51</a>]. (See <a href=\"#H525290250\" class=\"local\">'Changes in gut microbiota'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Aberrant expression of Toll-like receptors (TLR) has also been described in pouch patients with and without pouchitis [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/49,52,53\" class=\"abstract_t\">49,52,53</a>]. The increase in mucosal permeability to microbiota in the ileal pouch results in a mucosal immune response, as suggested by production of antimicrobial peptides by intestinal Paneth cells and other gut epithelial cells [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/44,49,52-56\" class=\"abstract_t\">44,49,52-56</a>]. The expression of Paneth-cell-specific human defensin-5 is increased in both inflamed and noninflamed pouches as compared with that in the normal terminal ileum [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/57-59\" class=\"abstract_t\">57-59</a>]. In addition, aberrant expression of human beta defensin-1 has been observed in patients with pouchitis [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/60\" class=\"abstract_t\">60</a>].</p><p/><p>Abnormalities in both molecular and cellular components of the gut adaptive immune system have been associated with pouch inflammation. However, the abnormal adaptive mucosal immunity likely represents the activation of nonspecific inflammatory cascade or pathways [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/61\" class=\"abstract_t\">61</a>]. Changes in adaptive immunity include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>An increased proliferation of immature plasma cells in inflamed pouch in patients with underlying ulcerative colitis [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/47,48,62\" class=\"abstract_t\">47,48,62</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Production of proinflammatory mediators including TNF,<sup> </sup>cell adhesion molecules, platelet-activating factor, lipoxygenase products of arachidonic acids, vascular endothelial growth factor, and proinflammatory neuropeptides [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/61,63-72\" class=\"abstract_t\">61,63-72</a>]. In addition, there is an imbalance in the production of proinflammatory (eg, IL-8) and immunoregulatory (eg, IL-10) cytokines [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/65\" class=\"abstract_t\">65</a>].</p><p/><p class=\"headingAnchor\" id=\"H525291236\"><span class=\"h1\">RISK FACTORS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although the pathogenesis of pouchitis is unclear, several risk factors have been identified.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Ulcerative colitis</strong> <strong>(UC)</strong> &ndash; A history of UC is the most important risk factor for pouchitis. Pouchitis almost exclusively occurs in patients with UC and rarely in patients with familial adenomatous polyposis (FAP). Among patients with UC, the risk of pouchitis is increased in patients with extensive colitis [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/73-78\" class=\"abstract_t\">73-78</a>]. In a prospective study that included 201 patients with ileal pouch-anal anastomosis (IPAA) with a mean follow-up of 108 months, patients with extensive UC had a threefold increased risk of chronic pouchitis as compared with patients with limited disease (odds ratio [OR] 3.3, 95% CI 1.2-8.9) [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/75\" class=\"abstract_t\">75</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Primary sclerosing cholangitis (PSC) and other immunological disorders</strong> &ndash; The risk of pouchitis is also increased in patients with UC and concurrent PSC [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/2,10,74,75,79,80\" class=\"abstract_t\">2,10,74,75,79,80</a>]. In a study that included 1097 patients with UC, of whom 54 had concurrent PSC, the cumulative risk of pouchitis after IPAA in patients with both UC and PSC was significantly higher at 1, 2, 5, and 10 years as compared with patients with UC alone (22, 43, 61, and 79 percent versus 16, 23, 36, 46 percent, respectively) [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/10\" class=\"abstract_t\">10</a>]. Patients with concurrent autoimmune disorders were found to have a higher risk for chronic antibiotic-refractory pouchitis (CARP) [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/81\" class=\"abstract_t\">81</a>]. CARP can also coexist with autoinflammatory disorders [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/82\" class=\"abstract_t\">82</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Smoking status</strong> &ndash; Smoking is associated with an increased risk of acute pouchitis but a decreased risk of chronic pouchitis [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/74,83\" class=\"abstract_t\">74,83</a>]. Although the mechanism behind the differential effects of smoking on the risk of acute and chronic pouchitis is not understood, it is hypothesized that smoking increases the risk of acute pouchitis by its effects on mucosal immunity and intestinal permeability. (See <a href=\"#H525290635\" class=\"local\">'Abnormal mucosal immunity'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Nonsteroidal anti-inflammatory drug (NSAID) use</strong> &ndash; Postoperative NSAID use has been associated with an increased risk of chronic pouchitis [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/73\" class=\"abstract_t\">73</a>]. In one study, withdrawal of NSAIDs in patients with ileal pouch disorders resulted in a significant reduction in disease activity and an improvement in symptoms [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/84\" class=\"abstract_t\">84</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Gender </strong>&ndash; Men appear to have a higher risk for chronic pouchitis as compared with women possibly due to mesenteric tension due to a short mesentery [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/85,86\" class=\"abstract_t\">85,86</a>]. The notion was further supported by a study comparing the outcome of J- and S-pouches. In a study of 215 patients with J-pouches and 45 with S-pouches, those with S-pouches were significantly less likely to develop CARP than those with J-pouches. The difference most likely results from the lower mesenteric tension from S-pouch construction [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/87\" class=\"abstract_t\">87</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Prior <span class=\"nowrap\">abdominal/pelvic</span> surgery</strong> &ndash; A history of<strong> </strong>multiple prior <span class=\"nowrap\">abdominal/pelvic</span> surgeries has been associated with pouchitis, possibly due to poor perfusion or ischemia during or after pouch construction [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/88\" class=\"abstract_t\">88</a>]. As an example, a strictured anastomosis is associated with a higher risk for pouchitis, presumably due to backflow of stool content and ischemia [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/89\" class=\"abstract_t\">89</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Other risk factors</strong> &ndash; Immune-mediated disorders, high serum IgG4, and autoantibodies to bacterial antigens as well as the host's self-tissue (eg, perinuclear antineutrophil cytoplasmic antibodies [p-ANCA] and anti-CBir1 flagellin antibody) have also been associated with an increase in the risk of pouchitis in some studies [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/75,90-94\" class=\"abstract_t\">75,90-94</a>].<sup> </sup>In a meta-analysis that included 335 patients with UC who had undergone IPAA and had acute or chronic pouchitis, individuals with a positive serology for ANCA were at an increased risk for chronic but not acute pouchitis as compared with individuals who were ANCA negative (odds ratio [OR] chronic pouchitis 1.8, 95% CI 1.2-2.6) [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/95\" class=\"abstract_t\">95</a>]. However, ANCA titers were measured following colectomy in most of the studies included in the meta-analysis, and the analysis did not adjust for important confounding variables that can increase the risk of pouchitis.</p><p/><p class=\"bulletIndent1\">Precolectomy thrombocytosis and portal vein thrombi have been associated with an increased risk of pouchitis due to ischemia [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/88,96\" class=\"abstract_t\">88,96</a>].</p><p/><p class=\"headingAnchor\" id=\"H6\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span></p><p class=\"headingAnchor\" id=\"H1755372193\"><span class=\"h2\">Clinical features</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with pouchitis typically have a wide range of clinical presentations, ranging from increased stool frequency, urgency, abdominal cramps, pelvic pressure, tenesmus, and night-time fecal seepage to incontinence. However, these symptoms are not specific and can be seen in patients with other inflammatory and noninflammatory disorders of the pouch [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/97\" class=\"abstract_t\">97</a>]. (See <a href=\"#H525293002\" class=\"local\">'Differential diagnosis'</a> below.)</p><p>It is also important to note that patients without pouchitis have four to seven soft bowel movements a day and that the normal baseline bowel frequency and stool consistency vary among patients. However, patients with healthy pouches do not have cramps, dyschezia, pelvic discomfort, tenesmus, and incontinence, and only have rare nocturnal symptoms.</p><p class=\"headingAnchor\" id=\"H1755372200\"><span class=\"h2\">Laboratory findings</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients may have iron deficiency anemia due to insufficient iron absorption or utilization or blood loss [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/98\" class=\"abstract_t\">98</a>]. Low serum vitamin D levels have also been reported in patients with ileal pouches, even in the absence of concurrent mucosal inflammation [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/99,100\" class=\"abstract_t\">99,100</a>]. Patients with concurrent primary sclerosing cholangitis or IgG4-associated cholangiopathy may have an elevation of alkaline phosphatase <span class=\"nowrap\">and/or</span> bilirubin. (See <a href=\"topic.htm?path=primary-sclerosing-cholangitis-in-adults-clinical-manifestations-and-diagnosis#H57943234\" class=\"medical medical_review\">&quot;Primary sclerosing cholangitis in adults: Clinical manifestations and diagnosis&quot;, section on 'Association with inflammatory bowel disease'</a> and <a href=\"topic.htm?path=overview-of-igg4-related-disease#H16601937\" class=\"medical medical_review\">&quot;Overview of IgG4-related disease&quot;, section on 'IgG4-related sclerosing cholangitis'</a>.)</p><p>As with other inflammatory pouch disorders (eg, cuffitis, active Crohn disease), fecal assays of lactoferrin and calprotectin and inflammatory markers in the blood (eg, C-reactive protein, alpha-1 antitrypsin) may be elevated in patients with pouchitis [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/101-106\" class=\"abstract_t\">101-106</a>]. Matrix metalloprotease-9 are also increased in patients with pouchitis [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/107\" class=\"abstract_t\">107</a>]. </p><p class=\"headingAnchor\" id=\"H1121783420\"><span class=\"h1\">EVALUATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Evaluation of a patient with suspected pouchitis serves to exclude other pouch disorders, establish the diagnosis of pouchitis, and determine the severity of the disease.</p><p class=\"headingAnchor\" id=\"H1755372101\"><span class=\"h2\">Diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pouchitis should be suspected in patients with an ileal pouch-anal anastomosis and increased stool frequency, urgency, abdominal cramps, pelvic pressure, tenesmus, or incontinence. Since these features are not specific to pouchitis, establishing the diagnosis also requires the exclusion of other diagnoses by history, laboratory evaluation, endoscopy and biopsy and, in some cases, <span class=\"nowrap\">abdominal/pelvic</span> imaging [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/97,108,109\" class=\"abstract_t\">97,108,109</a>].</p><p class=\"headingAnchor\" id=\"H242569\"><span class=\"h3\">History</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Symptoms of hematochezia are rare in patients with pouchitis and are suggestive of inflammation of the rectal cuff (cuffitis). Systemic symptoms including fever, chills, and weight loss are suggestive of an infectious cause of pouchitis (eg, <em>C. difficile </em>or cytomegalovirus [CMV]); Crohn disease of the pouch; or surgical complication (eg, pouch anastomosis sinus or leak). While patients with classic pouchitis often have a sense of incomplete evacuation, they typically do not have dyschezia or symptoms of obstructive defecation. The presence of dyschezia is suggestive of a pouch outlet or anastomotic stricture, distal pouch prolapse, angulation or prolapse of pouch inlet or pelvic dyssynergic contraction.</p><p class=\"headingAnchor\" id=\"H242174\"><span class=\"h3\">Laboratory studies</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Stool studies should include stool <em>C. difficile </em>toxin [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/84\" class=\"abstract_t\">84</a>]. For patients with systemic symptoms, such as fever, chills, night sweats, weight loss, and leukocytosis, stool cultures for other intestinal pathogens (eg, <em>Salmonella, Shigella, Campylobacter, Yersinia</em>) and specific testing for <em>E. coli </em>O157:H7 should be performed.</p><p class=\"headingAnchor\" id=\"H1727626618\"><span class=\"h3\">Endoscopy and biopsy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Endoscopic evaluation of an ileal pouch (pouchoscopy) should include the following:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Evaluation of the distensibility of the pouch body, the severity, extent, and distribution of mucosal inflammation.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Assessment of the prepouch ileum for Crohn disease and concurrent backwash enteritis.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Inspection of the rectal cuff or anal transitional zone to rule out cuffitis.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Biopsies of the pouch should be obtained, even in a normal-appearing pouch, as histologic inflammation may be present. Biopsies also serve to rule out Crohn disease, CMV infection, and ischemia. (See <a href=\"topic.htm?path=overview-of-diagnostic-tests-for-cytomegalovirus-infection#H5887771\" class=\"medical medical_review\">&quot;Overview of diagnostic tests for cytomegalovirus infection&quot;, section on 'Histopathology'</a>.)</p><p/><p>On pouchoscopy, pouchitis is characterized by the presence of diffuse erythema, friability, granularity, exudates, erosions, <span class=\"nowrap\">and/or</span> ulcerations [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/97,109\" class=\"abstract_t\">97,109</a>]. While not specific for pouchitis, in a chronically inflamed pouch, mucosal bridges, inflammatory polyps, poor distensibility of the pouch body, or the loss of &quot;owls' eye&quot; configuration of a J-pouch may be seen (<a href=\"image.htm?imageKey=GAST%2F93166\" class=\"graphic graphic_picture graphicRef93166 \">picture 2</a>) [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/110\" class=\"abstract_t\">110</a>]. Asymmetric distribution of inflammation in the pouch body (the presence of inflammation either at the afferent limb or at the efferent limb side of pouch body sparing the other half with a sharp demarcation of inflamed and noninflamed parts along the suture line or the presence of inflammation only in the distal pouch body sparing the proximal body) is suggestive of ischemic pouchitis (<a href=\"image.htm?imageKey=GAST%2F93161\" class=\"graphic graphic_picture graphicRef93161 \">picture 3</a>) [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/88\" class=\"abstract_t\">88</a>].</p><p>Pouchitis, by definition, involves the body of the reservoir. However, some patients with pouchitis can have the disease process involve in the distal afferent limb or neoterminal ileum (ie, prepouch <span class=\"nowrap\">ileitis/enteritis)</span>. Prepouch inflammation may be subclinical, submacroscopic, and even submicroscopic, as evidenced by the presence of altered gene transcripts in both ileum and pouch mucosa [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/111\" class=\"abstract_t\">111</a>].</p><p>On histology, pouchitis is characterized by acute inflammation with neutrophil infiltration, crypt abscess, and mucosal ulceration, often superimposed on a background of chronic changes, including villous atrophy, crypt distortion or hyperplasia, pyloric gland metaplasia, and chronic inflammatory cell infiltration (<a href=\"image.htm?imageKey=GAST%2F93165\" class=\"graphic graphic_picture graphicRef93165 \">picture 1</a>) [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/109,112\" class=\"abstract_t\">109,112</a>]. Pouchitis should not be diagnosed in the absence of acute inflammation as chronic inflammatory changes are common in ileal pouches due to chronic fecal stasis [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/50,113\" class=\"abstract_t\">50,113</a>]. The presence of crypt apoptosis is suggestive of autoimmune pouchitis [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/114,115\" class=\"abstract_t\">114,115</a>]. The diagnosis of CMV infection of the pouch is based on the presence of basophilic intranuclear inclusions, although eosinophilic cytoplasmic inclusions may also be seen. The diagnosis of CMV in tissue sections can be confirmed with immunohistochemical staining. (See <a href=\"topic.htm?path=overview-of-diagnostic-tests-for-cytomegalovirus-infection#H5887771\" class=\"medical medical_review\">&quot;Overview of diagnostic tests for cytomegalovirus infection&quot;, section on 'Histopathology'</a>.)</p><p>Several scoring systems have been used to grade the severity of inflammation in patients with pouchitis in research studies. One such scoring system is the 18-point Pouchitis Disease Activity Index (PDAI), consisting of symptom, endoscopy, and histology subscores (<a href=\"image.htm?imageKey=GAST%2F94138\" class=\"graphic graphic_table graphicRef94138 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/109\" class=\"abstract_t\">109</a>]. Although a diagnosis of pouchitis is suggested by a PDAI score of &ge;7 points, this is not specific and irritable pouch syndrome or other inflammatory disorders of the pouch (eg, cuffitis, Crohn disease of the pouch) can also elevate the PDAI [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/116\" class=\"abstract_t\">116</a>].</p><p class=\"headingAnchor\" id=\"H1820101\"><span class=\"h3\">Additional evaluation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In patients with antibiotic-refractory or antibiotic-dependent pouchitis, we perform additional tests to rule out other etiologies and identify pouch-related complications (eg, Crohn disease, stricture, abscess, sinus, or fistula). In patients who experience symptoms suggestive of pouchitis immediately after pouch construction and ileostomy closure and do not respond to the antibiotic therapy, surgery-associated complications, such as pouch anastomotic leaks or sinus, pelvic abscess, and pouch ischemia, should be suspected.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Additional laboratory studies</strong> &ndash; Laboratory testing should include [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/91,94,117\" class=\"abstract_t\">91,94,117</a>]:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Stool <em>C. difficile </em>toxin. In patients with severe pouchitis, we also test stool for <em>C. perfringens </em>[<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/118\" class=\"abstract_t\">118</a>].</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Serologic evaluation for celiac disease. (See <a href=\"topic.htm?path=diagnosis-of-celiac-disease-in-adults#H4\" class=\"medical medical_review\">&quot;Diagnosis of celiac disease in adults&quot;, section on 'Serologic evaluation'</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Serological markers associated with high risk of pouchitis and Crohn disease of the pouch including pANCA, anti-C-CBir 1 [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/92,93\" class=\"abstract_t\">92,93</a>], and anti-glycoprotein 2 [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/92,93,119\" class=\"abstract_t\">92,93,119</a>].</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Antinuclear antibody, antimicrosomal antibodies, and IgG4 to rule out primary sclerosing cholangitis and IgG4 cholangitis. (See <a href=\"topic.htm?path=primary-sclerosing-cholangitis-in-adults-clinical-manifestations-and-diagnosis#H2\" class=\"medical medical_review\">&quot;Primary sclerosing cholangitis in adults: Clinical manifestations and diagnosis&quot;, section on 'Clinical manifestations'</a> and <a href=\"topic.htm?path=overview-of-igg4-related-disease#H16601937\" class=\"medical medical_review\">&quot;Overview of IgG4-related disease&quot;, section on 'IgG4-related sclerosing cholangitis'</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Salicylate levels to assess nonsteroidal anti-inflammatory drug use.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong><span class=\"nowrap\">Abdominal/pelvic</span> imaging</strong> &ndash; We also perform <span class=\"nowrap\">abdominal/pelvic</span> imaging based on the patient's symptoms and physical examination findings [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>].</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>In patients with an increase in stool frequency, we perform a water-soluble contrast pouchogram (gastrografin enema) to delineate the pouch shape and anatomy and the presence of luminal angulation or dilation, polyps, prolapse, stricture, anastomotic sinus, or fistula.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>In patients with abdominal pain, bloating, direct or indirect evidence of a fistula (eg, vaginal discharge of gas or fecal materials, fecaluria, pneumaturia, recurrent urinary tract infections), we perform a computed tomography enterography or magnetic resonance enterography to evaluate the location, length, number of strictures, the presence of abscess, fistula, and inflammation of the pouch and small bowel [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/120\" class=\"abstract_t\">120</a>].</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>In patients with concurrent pelvic pain, fever, perianal fistula or indirect evidence of a fistula, we perform contrast-enhanced pelvic magnetic resonance imaging with fistula protocol to rule out abnormalities in and around the pouch including an anastomotic sinus, fistula, abscess, presacral sinus-associated osteomyelitis, pelvic fluid collection, and trapped ovarian syndrome.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>In patients with fecal incontinence, we perform an anorectal ultrasound to detect anal sphincter dysfunction due to anal sphincter injury, sinus, or fistula.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Examination under anesthesia</strong> &ndash; An examination under anesthesia by a colorectal surgeon should be reserved for patients with suspected Crohn disease-associated, anastomotic, iatrogenic, or cryptoglandular fistula [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/110\" class=\"abstract_t\">110</a>] and other inflammatory or structural abnormalities of the pouch.</p><p/><p class=\"headingAnchor\" id=\"H525293002\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Mechanical, inflammatory, and functional disorders of the pouch may have a similar clinical presentation as pouchitis [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/121\" class=\"abstract_t\">121</a>]. However, they can be differentiated from pouchitis based on history, pouchoscopy with biopsy, and imaging.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Cuffitis</strong> &ndash; Patients with cuffitis typically present with urgency and hematochezia [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/122\" class=\"abstract_t\">122</a>]. Cuffitis is considered as a recurrence of ulcerative colitis in the residual cuff of rectal mucosa and is distinguished from pouchitis by the distribution of inflammation on pouchoscopy and histology. It is important to note that pouchitis and cuffitis can coexist. Based on the response to topical medical therapy, cuffitis can be classified into <span class=\"nowrap\">steroid/mesalamine-responsive,</span> <span class=\"nowrap\">steroid/mesalamine-dependent,</span> and <span class=\"nowrap\">steroid/mesalamine-refractory</span> types.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>De novo Crohn disease (CD) </strong>&ndash; CD of the pouch can occur in patients with a preoperative diagnosis of ulcerative colitis or indeterminate colitis. CD of the pouch has inflammatory, fibrostenotic, and fistulizing phenotype, paralleling to the non-pouch CD. Patients with CD of the pouch usually have segmental inflammation of the pouch body <span class=\"nowrap\">and/or</span> afferent limb. In addition, patients with CD may have strictures at the pouch inlet or afferent limb, complex perianal fistulas, or late-onset (&gt;6 to 12 months after ileostomy closure) pouch-vaginal fistulas with an internal fistular orifice at the anal canal area.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Surgery-associated mechanical complications</strong> &ndash; An anastomotic sinus or leak may present with symptoms similar to that of pouchitis. Anastomotic strictures can be diagnosed by digital rectal examination. Pouch strictures are diagnosed by pouchoscopy or pouchogram. (See <a href=\"#H1820101\" class=\"local\">'Additional evaluation'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Decreased pouch compliance</strong> &ndash; Decreased compliance of the ileal pouch may be seen in patients with a history of pelvic sepsis. Patients may present with diarrhea, urgency, <span class=\"nowrap\">and/or</span> incontinence, and have evidence of decreased compliance on pouchogram and pelvic magnetic resonance imaging. (See <a href=\"#H1820101\" class=\"local\">'Additional evaluation'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Diversion pouchitis</strong> &ndash; Patients with diversion pouchitis present with anal discharge of blood <span class=\"nowrap\">and/or</span> mucus and urgency. Diversion pouchitis only develops in patients with an ileal pouch-anal anastomosis with a diverting ileostomy. (See <a href=\"topic.htm?path=diversion-colitis#H100554830\" class=\"medical medical_review\">&quot;Diversion colitis&quot;, section on 'Diversion pouchitis'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Irritable pouch syndrome (IPS) </strong>&ndash; IPS<strong> </strong>is a functional disorder associated with visceral hypersensitivity that is characterized by the presence of diarrhea, abdominal cramping, and urgency without endoscopic or histologic inflammation of the pouch [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/123\" class=\"abstract_t\">123</a>]. Histologic evaluation may show enterochromaffin cell hyperplasia on pouch biopsy; however, this is not required to diagnose IPS [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/124\" class=\"abstract_t\">124</a>]. The diagnosis of IPS requires the exclusion of both inflammatory and noninflammatory causes of pouch dysfunction. (See <a href=\"#H1121783420\" class=\"local\">'Evaluation'</a> above.)</p><p/><p class=\"headingAnchor\" id=\"H1835619414\"><span class=\"h1\">NATURAL HISTORY</span></p><p class=\"headingAnchor\" id=\"H10921945\"><span class=\"h2\">Disease course</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The majority of patients with acute pouchitis respond well to a short course of antibiotics. Approximately 40 percent of patients with acute pouchitis will have a single episode of pouchitis, and 60 percent will have at least one recurrence [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/2,125\" class=\"abstract_t\">2,125</a>]. Early onset of acute pouchitis immediately after pouch construction and ileostomy closure is associated with an increased risk for subsequent development of chronic pouchitis [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/126\" class=\"abstract_t\">126</a>]. However, the disease course of pouchitis varies among affected individuals (<a href=\"image.htm?imageKey=GAST%2F93162\" class=\"graphic graphic_figure graphicRef93162 \">figure 1</a>). It is estimated that 5 to 19 percent of patients with acute pouchitis develop chronic antibiotic refractory pouchitis (CARP) [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/125,127-129\" class=\"abstract_t\">125,127-129</a>]. In addition, a subset of patients with CARP can develop de novo Crohn disease of the pouch. CARP is an important cause for pouch failure and requires permanent diversion, pouch excision, or pouch revision [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/130\" class=\"abstract_t\">130</a>]. (See <a href=\"topic.htm?path=restorative-proctocolectomy-with-ileal-pouch-anal-anastomosis-laparoscopic-approach#H7533549\" class=\"medical medical_review\">&quot;Restorative proctocolectomy with ileal pouch-anal anastomosis: Laparoscopic approach&quot;, section on 'Risk factors for pouch failure'</a>.)</p><p class=\"headingAnchor\" id=\"H10921951\"><span class=\"h2\">Dysplasia or colorectal cancer</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The incidence of pouch-associated neoplasia in patients with ileal pouch-anal anastomosis (IPAA) is low. Adenocarcinoma in IPAA patients is almost exclusively located at the anal transitional zone or cuff, and isolated cancer in the pouch body is extremely rare [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/131,132\" class=\"abstract_t\">131,132</a>]. A history of prior neoplasia in the colon or rectum is a strong risk factor for the development of pouch neoplasia [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/132,133\" class=\"abstract_t\">132,133</a>]. Other risk factors may include primary sclerosing cholangitis, chronic pouchitis or cuffitis, and a family history of colorectal cancer. (See <a href=\"topic.htm?path=primary-sclerosing-cholangitis-inflammatory-bowel-disease-and-colorectal-cancer\" class=\"medical medical_review\">&quot;Primary sclerosing cholangitis: Inflammatory bowel disease and colorectal cancer&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In a historical cohort study of 3203 patients, the cumulative incidence for pouch neoplasia at 5, 10, 15, 20, and 25 years after pouch construction was 0.9, 1.3, 1.9, 4.2, and 5.1 percent, respectively. The cumulative incidence of pouch cancer (including adenocarcinoma, lymphoma, and squamous cell cancer) at 5, 10, 15, 20, and 25 years after IPAA was 0.2, 0.4, 0.8, 2.4, and 3.4 percent, respectively [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/132\" class=\"abstract_t\">132</a>]. A preoperative diagnosis of ulcerative colitis-associated dysplasia or cancer was associated with an increased risk of pouch neoplasia (hazard ratio [HR] 3.6, 95% CI 1.6-8.2 and 13.4, 95% CI 4.0-45.5, respectively).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In another observational study that included 1200 patients identified from a Dutch national pathology database, the cumulative incidences at 5, 10, 15, and 20 years for pouch neoplasia and pouch carcinoma were 1.0, 2.0, 3.7, and 6.9 percent and 0.6, 1.4, 2.1, and 3.3 percent, respectively [<a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/133\" class=\"abstract_t\">133</a>]. A history of prior dysplasia and colorectal cancer was associated with an increased risk for pouch neoplasia (HR 3.8, 95% CI 1.4-10.2 and 24.7, 95% CI 9.6-63.4, respectively).</p><p/><p class=\"headingAnchor\" id=\"H1820268\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pouchitis is an inflammatory condition of the ileal pouch reservoir of an ileal pouch-anal anastomosis (IPAA) or continent ileostomy (eg, Koch pouch). Pouchitis can be classified based on the duration of symptoms (acute versus chronic), response to antibiotics (antibiotic responsive versus antibiotic-dependent versus antibiotic-refractory), the frequency of flares (infrequent versus relapsing), and the underlying etiology (idiopathic versus secondary). (See <a href=\"#H1335092930\" class=\"local\">'Definition'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Among patients who have undergone an IPAA, the incidence of pouchitis ranges from 23 to 59 percent. The pathogenesis of pouchitis is unclear, but it is hypothesized to result from an abnormal immune response to altered luminal <span class=\"nowrap\">and/or</span> mucosal bacteria in genetically susceptible hosts. (See <a href=\"#H2\" class=\"local\">'Epidemiology'</a> above and <a href=\"#H3\" class=\"local\">'Pathogenesis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A history of ulcerative colitis (UC) is the most important risk factor for pouchitis. Among patients with UC, the risk of pouchitis is increased in patients with extensive colitis and in patients with concurrent primary sclerosing cholangitis (PSC). Smoking is associated with an increased risk of acute pouchitis but a decreased risk of chronic pouchitis. Postoperative nonsteroidal anti-inflammatory drug use has been associated with an increased risk of chronic pouchitis. (See <a href=\"#H525291236\" class=\"local\">'Risk factors'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pouchitis should be suspected in patients with an IPAA and increased stool frequency, urgency, abdominal cramps, pelvic pressure, tenesmus, or incontinence. On pouch endoscopy (pouchoscopy), pouchitis is characterized by the presence of diffuse erythema, friability, granularity, exudates, erosions, <span class=\"nowrap\">and/or</span> ulcerations. On histology, pouchitis is characterized by acute inflammation with neutrophil infiltration, crypt abscess, and mucosal ulceration, often superimposed on a background of chronic changes, including villous atrophy, crypt distortion or hyperplasia, pyloric gland metaplasia, and chronic inflammatory cell infiltration. (See <a href=\"#H1755372193\" class=\"local\">'Clinical features'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Since the clinical, endoscopic, and histologic features of pouchitis are not specific, establishing the diagnosis requires the exclusion of other diagnoses by laboratory evaluation, pouchoscopy with biopsy, and, in some cases, <span class=\"nowrap\">abdominal/pelvic</span> imaging. (See <a href=\"#H1121783420\" class=\"local\">'Evaluation'</a> above and <a href=\"#H525293002\" class=\"local\">'Differential diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The majority of patients have acute pouchitis that responds well to a short course of antibiotics. Approximately 40 percent of patients with acute pouchitis will have a single episode of pouchitis, and 60 percent will have at least one recurrence. Approximately 5 to 19 percent of patients with acute pouchitis develop chronic antibiotic refractory pouchitis. (See <a href=\"#H10921945\" class=\"local\">'Disease course'</a> above and <a href=\"topic.htm?path=pouchitis-management#H3136328003\" class=\"medical medical_review\">&quot;Pouchitis: Management&quot;, section on 'Management of acute pouchitis'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The incidence of pouch-associated neoplasia is low. Adenocarcinoma in IPAA patients is almost exclusively located at the anal transitional zone or cuff, and isolated cancer in the pouch body is extremely rare. A history of colitis-associated neoplasia in the colon or rectum is a strong risk factor for the development of pouch neoplasia. Other risk factors include PSC, chronic pouchitis or cuffitis, and a family history of colorectal cancer. (See <a href=\"#H10921951\" class=\"local\">'Dysplasia or colorectal cancer'</a> above.)</p><p/><p class=\"headingAnchor\" id=\"H802830940\"><span class=\"h1\">ACKNOWLEDGMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The editorial staff at UpToDate would like to acknowledge Dr. Mark Peppercorn, who contributed to an earlier version of this topic review.</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/1\" class=\"nounderline abstract_t\">Pardi DS, D'Haens G, Shen B, et al. Clinical guidelines for the management of pouchitis. Inflamm Bowel Dis 2009; 15:1424.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/2\" class=\"nounderline abstract_t\">Lohmuller JL, Pemberton JH, Dozois RR, et al. Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg 1990; 211:622.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/3\" class=\"nounderline abstract_t\">Mignon M, Stettler C, Phillips SF. Pouchitis--a poorly understood entity. Dis Colon Rectum 1995; 38:100.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/4\" class=\"nounderline abstract_t\">Sandborn WJ. Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 1994; 107:1856.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/5\" class=\"nounderline abstract_t\">Romanos J, Samarasekera DN, Stebbing JF, et al. Outcome of 200 restorative proctocolectomy operations: the John Radcliffe Hospital experience. Br J Surg 1997; 84:814.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/6\" class=\"nounderline abstract_t\">St&aring;hlberg D, Gullberg K, Liljeqvist L, et al. Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors. Dis Colon Rectum 1996; 39:1012.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/7\" class=\"nounderline abstract_t\">Ker&auml;nen U, Luukkonen P, J&auml;rvinen H. Functional results after restorative proctocolectomy complicated by pouchitis. Dis Colon Rectum 1997; 40:764.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/8\" class=\"nounderline abstract_t\">Dozois RR, Goldberg SM, Rothenberger DA, et al. Restorative proctocolectomy with ileal reservoir. Int J Colorectal Dis 1986; 1:2.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/9\" class=\"nounderline abstract_t\">Fonkalsrud EW. Endorectal ileoanal anastomosis with isoperistaltic ileal reservoir after colectomy and mucosal proctectomy. Ann Surg 1984; 199:151.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/10\" class=\"nounderline abstract_t\">Penna C, Dozois R, Tremaine W, et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 1996; 38:234.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/11\" class=\"nounderline abstract_t\">Fazio VW, Kiran RP, Remzi FH, et al. Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients. Ann Surg 2013; 257:679.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/12\" class=\"nounderline abstract_t\">Ferrante M, Declerck S, De Hertogh G, et al. Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Inflamm Bowel Dis 2008; 14:20.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/13\" class=\"nounderline abstract_t\">Simchuk EJ, Thirlby RC. Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomoses. World J Surg 2000; 24:851.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/14\" class=\"nounderline abstract_t\">Hueting WE, Buskens E, van der Tweel I, et al. Results and complications after ileal pouch anal anastomosis: a meta-analysis of 43 observational studies comprising 9,317 patients. Dig Surg 2005; 22:69.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/15\" class=\"nounderline abstract_t\">Mahadevan U, Sandborn WJ. Diagnosis and management of pouchitis. Gastroenterology 2003; 124:1636.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/16\" class=\"nounderline abstract_t\">Carter MJ, Di Giovine FS, Cox A, et al. The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis. Gastroenterology 2001; 121:805.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/17\" class=\"nounderline abstract_t\">Sehgal R, Berg A, Hegarty JP, et al. NOD2/CARD15 mutations correlate with severe pouchitis after ileal pouch-anal anastomosis. Dis Colon Rectum 2010; 53:1487.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/18\" class=\"nounderline abstract_t\">Meier CB, Hegazi RA, Aisenberg J, et al. Innate immune receptor genetic polymorphisms in pouchitis: is CARD15 a susceptibility factor? Inflamm Bowel Dis 2005; 11:965.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/19\" class=\"nounderline abstract_t\">Tyler AD, Milgrom R, Stempak JM, et al. The NOD2insC polymorphism is associated with worse outcome following ileal pouch-anal anastomosis for ulcerative colitis. Gut 2013; 62:1433.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/20\" class=\"nounderline abstract_t\">Lammers KM, Ouburg S, Morr&eacute; SA, et al. Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis. World J Gastroenterol 2005; 11:7323.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/21\" class=\"nounderline abstract_t\">Sehgal R, Berg A, Polinski JI, et al. Genetic risk profiling and gene signature modeling to predict risk of complications after IPAA. Dis Colon Rectum 2012; 55:239.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/22\" class=\"nounderline abstract_t\">Kabakchiev B, Tyler A, Stempak JM, et al. Downregulation of expression of xenobiotic efflux genes is associated with pelvic pouch inflammation in ulcerative colitis. Inflamm Bowel Dis 2014; 20:1157.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/23\" class=\"nounderline abstract_t\">de Silva HJ, Millard PR, Soper N, et al. Effects of the faecal stream and stasis on the ileal pouch mucosa. Gut 1991; 32:1166.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/24\" class=\"nounderline abstract_t\">Coffey JC, Rowan F, Burke J, et al. Pathogenesis of and unifying hypothesis for idiopathic pouchitis. Am J Gastroenterol 2009; 104:1013.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/25\" class=\"nounderline abstract_t\">Kohyama A, Ogawa H, Funayama Y, et al. Bacterial population moves toward a colon-like community in the pouch after total proctocolectomy. Surgery 2009; 145:435.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/26\" class=\"nounderline abstract_t\">Sokol H, Lay C, Seksik P, Tannock GW. Analysis of bacterial bowel communities of IBD patients: what has it revealed? Inflamm Bowel Dis 2008; 14:858.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/27\" class=\"nounderline abstract_t\">McLaughlin SD, Walker AW, Churcher C, et al. The bacteriology of pouchitis: a molecular phylogenetic analysis using 16S rRNA gene cloning and sequencing. Ann Surg 2010; 252:90.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/28\" class=\"nounderline abstract_t\">Tannock GW, Lawley B, Munro K, et al. Comprehensive analysis of the bacterial content of stool from patients with chronic pouchitis, normal pouches, or familial adenomatous polyposis pouches. Inflamm Bowel Dis 2012; 18:925.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/29\" class=\"nounderline abstract_t\">Scarpa M, Grillo A, Faggian D, et al. Relationship between mucosa-associated microbiota and inflammatory parameters in the ileal pouch after restorative proctocolectomy for ulcerative colitis. Surgery 2011; 150:56.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/30\" class=\"nounderline abstract_t\">Reshef L, Kovacs A, Ofer A, et al. Pouch Inflammation Is Associated With a Decrease in Specific Bacterial Taxa. Gastroenterology 2015; 149:718.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/31\" class=\"nounderline abstract_t\">Morgan XC, Kabakchiev B, Waldron L, et al. Associations between host gene expression, the mucosal microbiome, and clinical outcome in the pelvic pouch of patients with inflammatory bowel disease. Genome Biol 2015; 16:67.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/32\" class=\"nounderline abstract_t\">Shen BO, Jiang ZD, Fazio VW, et al. Clostridium difficile infection in patients with ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 2008; 6:782.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/33\" class=\"nounderline abstract_t\">Li Y, Qian J, Queener E, Shen B. Risk factors and outcome of PCR-detected Clostridium difficile infection in ileal pouch patients. Inflamm Bowel Dis 2013; 19:397.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/34\" class=\"nounderline abstract_t\">Shen B, Remzi FH, Fazio VW. Fulminant Clostridium difficile-associated pouchitis with a fatal outcome. Nat Rev Gastroenterol Hepatol 2009; 6:492.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/35\" class=\"nounderline abstract_t\">Shen B. Campylobacter infection in patients with ileal pouches. Am J Gastroenterol 2010; 105:472.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/36\" class=\"nounderline abstract_t\">Lan N, Patil DT, Shen B. Histoplasma capsulatum infection in refractory Crohn's disease of the pouch on anti-TNF biological therapy. Am J Gastroenterol 2013; 108:281.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/37\" class=\"nounderline abstract_t\">McCurdy JD, Loftus EV Jr, Tremaine WJ, et al. Cytomegalovirus infection of the ileoanal pouch: clinical characteristics and outcomes. Inflamm Bowel Dis 2013; 19:2394.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/38\" class=\"nounderline abstract_t\">Falk A, Olsson C, Ahrn&eacute; S, et al. Ileal pelvic pouch microbiota from two former ulcerative colitis patients, analysed by DNA-based methods, were unstable over time and showed the presence of Clostridium perfringens. Scand J Gastroenterol 2007; 42:973.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/39\" class=\"nounderline abstract_t\">Ingram S, McKinley JM, Vasey F, et al. Are inflammatory bowel disease (IBD) and pouchitis a reactive enteropathy to group D streptococci (Enterococci)? Inflamm Bowel Dis 2009; 15:1609.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/40\" class=\"nounderline abstract_t\">Gosselink MP, Schouten WR, van Lieshout LM, et al. Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis. Dis Colon Rectum 2004; 47:1519.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/41\" class=\"nounderline abstract_t\">Mu&ntilde;oz-Juarez M, Pemberton JH, Sandborn WJ, et al. Misdiagnosis of specific cytomegalovirus infection of the ileoanal pouch as refractory idiopathic chronic pouchitis: report of two cases. Dis Colon Rectum 1999; 42:117.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/42\" class=\"nounderline abstract_t\">Moonka D, Furth EE, MacDermott RP, Lichtenstein GR. Pouchitis associated with primary cytomegalovirus infection. Am J Gastroenterol 1998; 93:264.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/43\" class=\"nounderline abstract_t\">de Silva HJ, Jones M, Prince C, et al. Lymphocyte and macrophage subpopulations in pelvic ileal pouches. Gut 1991; 32:1160.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/44\" class=\"nounderline abstract_t\">Kroesen AJ, Leistenschneider P, Lehmann K, et al. Increased bacterial permeation in long-lasting ileoanal pouches. Inflamm Bowel Dis 2006; 12:736.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/45\" class=\"nounderline abstract_t\">Hirata I, Berrebi G, Austin LL, et al. Immunohistological characterization of intraepithelial and lamina propria lymphocytes in control ileum and colon and in inflammatory bowel disease. Dig Dis Sci 1986; 31:593.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/46\" class=\"nounderline abstract_t\">Stallmach A, Sch&auml;fer F, Hoffmann S, et al. Increased state of activation of CD4 positive T cells and elevated interferon gamma production in pouchitis. Gut 1998; 43:499.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/47\" class=\"nounderline abstract_t\">Thomas PD, Forbes A, Nicholls RJ, Ciclitira PJ. Altered expression of the lymphocyte activation markers CD30 and CD27 in patients with pouchitis. Scand J Gastroenterol 2001; 36:258.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/48\" class=\"nounderline abstract_t\">Goldberg PA, Herbst F, Beckett CG, et al. Leucocyte typing, cytokine expression, and epithelial turnover in the ileal pouch in patients with ulcerative colitis and familial adenomatous polyposis. Gut 1996; 38:549.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/49\" class=\"nounderline abstract_t\">Scarpa M, Grillo A, Pozza A, et al. TLR2 and TLR4 up-regulation and colonization of the ileal mucosa by Clostridiaceae spp. in chronic/relapsing pouchitis. J Surg Res 2011; 169:e145.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/50\" class=\"nounderline abstract_t\">Shepherd NA, Healey CJ, Warren BF, et al. Distribution of mucosal pathology and an assessment of colonic phenotypic change in the pelvic ileal reservoir. Gut 1993; 34:101.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/51\" class=\"nounderline abstract_t\">Merrett MN, Soper N, Mortensen N, Jewell DP. Intestinal permeability in the ileal pouch. Gut 1996; 39:226.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/52\" class=\"nounderline abstract_t\">Toiyama Y, Araki T, Yoshiyama S, et al. The expression patterns of Toll-like receptors in the ileal pouch mucosa of postoperative ulcerative colitis patients. Surg Today 2006; 36:287.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/53\" class=\"nounderline abstract_t\">Heuschen G, Leowardi C, Hinz U, et al. Differential expression of toll-like receptor 3 and 5 in ileal pouch mucosa of ulcerative colitis patients. Int J Colorectal Dis 2007; 22:293.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/54\" class=\"nounderline abstract_t\">Porter EM, van Dam E, Valore EV, Ganz T. Broad-spectrum antimicrobial activity of human intestinal defensin 5. Infect Immun 1997; 65:2396.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/55\" class=\"nounderline abstract_t\">Ayabe T, Satchell DP, Wilson CL, et al. Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol 2000; 1:113.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/56\" class=\"nounderline abstract_t\">Salzman NH, Ghosh D, Huttner KM, et al. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 2003; 422:522.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/57\" class=\"nounderline abstract_t\">Wehkamp J, Salzman NH, Porter E, et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A 2005; 102:18129.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/58\" class=\"nounderline abstract_t\">Scarpa M, Grillo A, Scarpa M, et al. Innate immune environment in ileal pouch mucosa: &alpha;5 defensin up-regulation as predictor of chronic/relapsing pouchitis. J Gastrointest Surg 2012; 16:188.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/59\" class=\"nounderline abstract_t\">Masters SL, Simon A, Aksentijevich I, Kastner DL. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). Annu Rev Immunol 2009; 27:621.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/60\" class=\"nounderline abstract_t\">Kiehne K, Brunke G, Wegner F, et al. Defensin expression in chronic pouchitis in patients with ulcerative colitis or familial adenomatous polyposis coli. World J Gastroenterol 2006; 12:1056.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/61\" class=\"nounderline abstract_t\">Schmidt C, Giese T, Ludwig B, et al. Increased cytokine transcripts in pouchitis reflect the degree of inflammation but not the underlying entity. Int J Colorectal Dis 2006; 21:419.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/62\" class=\"nounderline abstract_t\">Hirata N, Oshitani N, Kamata N, et al. Proliferation of immature plasma cells in pouchitis mucosa in patients with ulcerative colitis. Inflamm Bowel Dis 2008; 14:1084.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/63\" class=\"nounderline abstract_t\">Patel RT, Bain I, Youngs D, Keighley MR. Cytokine production in pouchitis is similar to that in ulcerative colitis. Dis Colon Rectum 1995; 38:831.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/64\" class=\"nounderline abstract_t\">Gionchetti P, Campieri M, Belluzzi A, et al. Mucosal concentrations of interleukin-1 beta, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in pelvic ileal pouches. Dig Dis Sci 1994; 39:1525.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/65\" class=\"nounderline abstract_t\">Bulois P, Tremaine WJ, Maunoury V, et al. Pouchitis is associated with mucosal imbalance between interleukin-8 and interleukin-10. Inflamm Bowel Dis 2000; 6:157.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/66\" class=\"nounderline abstract_t\">Patel RT, Pall AA, Adu D, Keighley MR. Circulating soluble adhesion molecules in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995; 7:1037.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/67\" class=\"nounderline abstract_t\">Chaussade S, Denizot Y, Valleur P, et al. Presence of PAF-acether in stool of patients with pouch ileoanal anastomosis and pouchitis. Gastroenterology 1991; 100:1509.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/68\" class=\"nounderline abstract_t\">Gertner DJ, Rampton DS, Madden MV, et al. Increased leukotriene B4 release from ileal pouch mucosa in ulcerative colitis compared with familial adenomatous polyposis. Gut 1994; 35:1429.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/69\" class=\"nounderline abstract_t\">Romano M, Cuomo A, Tuccillo C, et al. Vascular endothelial growth factor and cyclooxygenase-2 are overexpressed in ileal pouch-anal anastomosis. Dis Colon Rectum 2007; 50:650.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/70\" class=\"nounderline abstract_t\">Stucchi AF, Shebani KO, Leeman SE, et al. A neurokinin 1 receptor antagonist reduces an ongoing ileal pouch inflammation and the response to a subsequent inflammatory stimulus. Am J Physiol Gastrointest Liver Physiol 2003; 285:G1259.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/71\" class=\"nounderline abstract_t\">Stallmach A, Chan CC, Ecker KW, et al. Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis. Gut 2000; 47:415.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/72\" class=\"nounderline abstract_t\">Ulisse S, Gionchetti P, D'Al&ograve; S, et al. Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment. Am J Gastroenterol 2001; 96:2691.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/73\" class=\"nounderline abstract_t\">Achkar JP, Al-Haddad M, Lashner B, et al. Differentiating risk factors for acute and chronic pouchitis. Clin Gastroenterol Hepatol 2005; 3:60.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/74\" class=\"nounderline abstract_t\">Merrett MN, Mortensen N, Kettlewell M, Jewell DO. Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis. Gut 1996; 38:362.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/75\" class=\"nounderline abstract_t\">Hashavia E, Dotan I, Rabau M, et al. Risk factors for chronic pouchitis after ileal pouch-anal anastomosis: a prospective cohort study. Colorectal Dis 2012; 14:1365.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/76\" class=\"nounderline abstract_t\">de Silva HJ, de Angelis CP, Soper N, et al. Clinical and functional outcome after restorative proctocolectomy. Br J Surg 1991; 78:1039.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/77\" class=\"nounderline abstract_t\">Schmidt CM, Lazenby AJ, Hendrickson RJ, Sitzmann JV. Preoperative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure. Ann Surg 1998; 227:654.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/78\" class=\"nounderline abstract_t\">White E, Melmed GY, Vasiliauskas EA, et al. A prospective analysis of clinical variables, serologic factors, and outcome of ileal pouch-anal anastomosis in patients with backwash ileitis. Dis Colon Rectum 2010; 53:987.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/79\" class=\"nounderline abstract_t\">Hata K, Watanabe T, Shinozaki M, Nagawa H. Patients with extraintestinal manifestations have a higher risk of developing pouchitis in ulcerative colitis: multivariate analysis. Scand J Gastroenterol 2003; 38:1055.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/80\" class=\"nounderline abstract_t\">Lepist&ouml; A, K&auml;rkk&auml;inen P, J&auml;rvinen HJ. Prevalence of primary sclerosing cholangitis in ulcerative colitis patients undergoing proctocolectomy and ileal pouch-anal anastomosis. Inflamm Bowel Dis 2008; 14:775.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/81\" class=\"nounderline abstract_t\">Seril DN, Yao Q, Lashner BA, Shen B. Autoimmune features are associated with chronic antibiotic-refractory pouchitis. Inflamm Bowel Dis 2015; 21:110.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/82\" class=\"nounderline abstract_t\">Seril DN, Yao Q, Shen B. Auto-inflammatory diseases in ileal pouch patients with NOD2/CARD15 mutations. Gastroenterol Rep (Oxf) 2016; 4:73.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/83\" class=\"nounderline abstract_t\">Fleshner P, Ippoliti A, Dubinsky M, et al. A prospective multivariate analysis of clinical factors associated with pouchitis after ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 2007; 5:952.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/84\" class=\"nounderline abstract_t\">Shen B, Fazio VW, Remzi FH, et al. Effect of withdrawal of nonsteroidal anti-inflammatory drug use on ileal pouch disorders. Dig Dis Sci 2007; 52:3321.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/85\" class=\"nounderline abstract_t\">Wu XR, Ashburn J, Remzi FH, et al. Male Gender Is Associated with a High Risk for Chronic Antibiotic-Refractory Pouchitis and Ileal Pouch Anastomotic Sinus. J Gastrointest Surg 2016; 20:631.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/86\" class=\"nounderline abstract_t\">Wu XR, Kirat HT, Xhaja X, et al. The impact of mesenteric tension on pouch outcome and quality of life in patients undergoing restorative proctocolectomy. Colorectal Dis 2014; 16:986.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/87\" class=\"nounderline abstract_t\">Mukewar S, Wu X, Lopez R, Shen B. Comparison of long-term outcomes of S and J pouches and continent ileostomies in ulcerative colitis patients with restorative proctocolectomy-experience in subspecialty pouch center. J Crohns Colitis 2014; 8:1227.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/88\" class=\"nounderline abstract_t\">Shen B, Plesec TP, Remer E, et al. Asymmetric endoscopic inflammation of the ileal pouch: a sign of ischemic pouchitis? Inflamm Bowel Dis 2010; 16:836.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/89\" class=\"nounderline abstract_t\">Banasiewicz T, Marciniak R, Kaczmarek E, et al. The diameter of the ileal J-pouch-anal anastomosis as an important risk factor of pouchitis - clinical observations. Med Sci Monit 2011; 17:CR91.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/90\" class=\"nounderline abstract_t\">Shen B, Remzi FH, Nutter B, et al. Association between immune-associated disorders and adverse outcomes of ileal pouch-anal anastomosis. Am J Gastroenterol 2009; 104:655.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/91\" class=\"nounderline abstract_t\">Navaneethan U, Venkatesh PG, Kapoor S, et al. Elevated serum IgG4 is associated with chronic antibiotic-refractory pouchitis. J Gastrointest Surg 2011; 15:1556.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/92\" class=\"nounderline abstract_t\">Fleshner P, Ippoliti A, Dubinsky M, et al. Both preoperative perinuclear antineutrophil cytoplasmic antibody and anti-CBir1 expression in ulcerative colitis patients influence pouchitis development after ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 2008; 6:561.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/93\" class=\"nounderline abstract_t\">Fleshner PR, Vasiliauskas EA, Kam LY, et al. High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut 2001; 49:671.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/94\" class=\"nounderline abstract_t\">Kuisma J, J&auml;rvinen H, Kahri A, F&auml;rkkil&auml; M. Factors associated with disease activity of pouchitis after surgery for ulcerative colitis. Scand J Gastroenterol 2004; 39:544.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/95\" class=\"nounderline abstract_t\">Singh S, Sharma PK, Loftus EV Jr, Pardi DS. Meta-analysis: serological markers and the risk of acute and chronic pouchitis. Aliment Pharmacol Ther 2013; 37:867.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/96\" class=\"nounderline abstract_t\">Okon A, Dubinsky M, Vasiliauskas EA, et al. Elevated platelet count before ileal pouch-anal anastomosis for ulcerative colitis is associated with the development of chronic pouchitis. Am Surg 2005; 71:821.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/97\" class=\"nounderline abstract_t\">Shen B, Achkar JP, Lashner BA, et al. Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology 2001; 121:261.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/98\" class=\"nounderline abstract_t\">M'Koma AE, Wise PE, Schwartz DA, et al. Prevalence and outcome of anemia after restorative proctocolectomy: a clinical literature review. Dis Colon Rectum 2009; 52:726.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/99\" class=\"nounderline abstract_t\">Miller HL, Farraye FA, Coukos J, et al. Vitamin D deficiency and insufficiency are common in ulcerative colitis patients after ileal pouch-anal anastomosis. Inflamm Bowel Dis 2013; 19:E25.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/100\" class=\"nounderline abstract_t\">Khanna R, Wu X, Shen B. Low levels of vitamin D are common in patients with ileal pouches irrespective of pouch inflammation. J Crohns Colitis 2013; 7:525.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/101\" class=\"nounderline abstract_t\">Parsi MA, Shen B, Achkar JP, et al. Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis. Gastroenterology 2004; 126:1280.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/102\" class=\"nounderline abstract_t\">Lim M, Gonsalves S, Thekkinkattil D, et al. The assessment of a rapid noninvasive immunochromatographic assay test for fecal lactoferrin in patients with suspected inflammation of the ileal pouch. Dis Colon Rectum 2008; 51:96.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/103\" class=\"nounderline abstract_t\">Parsi MA, Ellis JJ, Lashner BA. Cost-effectiveness of quantitative fecal lactoferrin assay for diagnosis of symptomatic patients with ileal pouch-anal anastomosis. J Clin Gastroenterol 2008; 42:799.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/104\" class=\"nounderline abstract_t\">Johnson MW, Maestranzi S, Duffy AM, et al. Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis. Eur J Gastroenterol Hepatol 2008; 20:174.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/105\" class=\"nounderline abstract_t\">Matalon S, Elad H, Brazowski E, et al. Serum alpha-1 antitrypsin: a noninvasive marker of pouchitis. Inflamm Bowel Dis 2015; 21:589.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/106\" class=\"nounderline abstract_t\">Yamamoto T, Shimoyama T, Bamba T, Matsumoto K. Consecutive Monitoring of Fecal Calprotectin and Lactoferrin for the Early Diagnosis and Prediction of Pouchitis after Restorative Proctocolectomy for Ulcerative Colitis. Am J Gastroenterol 2015; 110:881.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/107\" class=\"nounderline abstract_t\">Farkas K, B&aacute;lint A, Bor R, et al. Faecal matrix metalloprotease-9 is a more sensitive marker for diagnosing pouchitis than faecal calprotectin: results from a pilot study. Expert Rev Gastroenterol Hepatol 2015; 9:387.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/108\" class=\"nounderline abstract_t\">Tang L, Cai H, Moore L, Shen B. Evaluation of endoscopic and imaging modalities in the diagnosis of structural disorders of the ileal pouch. Inflamm Bowel Dis 2010; 16:1526.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/109\" class=\"nounderline abstract_t\">Moskowitz RL, Shepherd NA, Nicholls RJ. An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir. Int J Colorectal Dis 1986; 1:167.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/110\" class=\"nounderline abstract_t\">Elder K, Lopez R, Kiran RP, et al. Endoscopic features associated with ileal pouch failure. Inflamm Bowel Dis 2013; 19:1202.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/111\" class=\"nounderline abstract_t\">Yanai H, Ben-Shachar S, Baram L, et al. Gene expression alterations in ulcerative colitis patients after restorative proctocolectomy extend to the small bowel proximal to the pouch. Gut 2015; 64:756.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/112\" class=\"nounderline abstract_t\">Shepherd NA, Jass JR, Duval I, et al. Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens. J Clin Pathol 1987; 40:601.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/113\" class=\"nounderline abstract_t\">de Silva HJ, Millard PR, Kettlewell M, et al. Mucosal characteristics of pelvic ileal pouches. Gut 1991; 32:61.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/114\" class=\"nounderline abstract_t\">Kariv R, Plesec TP, Gaffney K, et al. Pyloric gland metaplasia and pouchitis in patients with ileal pouch-anal anastomoses. Aliment Pharmacol Ther 2010; 31:862.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/115\" class=\"nounderline abstract_t\">Jiang W, Goldblum JR, Lopez R, et al. Increased crypt apoptosis is a feature of autoimmune-associated chronic antibiotic refractory pouchitis. Dis Colon Rectum 2012; 55:549.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/116\" class=\"nounderline abstract_t\">Ben-Bassat O, Tyler AD, Xu W, et al. Ileal pouch symptoms do not correlate with inflammation of the pouch. Clin Gastroenterol Hepatol 2014; 12:831.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/117\" class=\"nounderline abstract_t\">Navaneethan U, Venkatesh PG, Manilich E, et al. Prevalence and clinical implications of positive serum anti-microsomal antibodies in symptomatic patients with ileal pouches. J Gastrointest Surg 2011; 15:1577.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/118\" class=\"nounderline abstract_t\">Machiels K, Sabino J, Vandermosten L, et al. Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC. Gut 2017; 66:79.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/119\" class=\"nounderline abstract_t\">Werner L, Sturm A, Roggenbuck D, et al. Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch. J Crohns Colitis 2013; 7:e522.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/120\" class=\"nounderline abstract_t\">Sahi KS, Lee KS, Moss A, et al. MR Enterography of the Ileoanal Pouch: Descriptive Radiologic Analysis With Endoscopic and Pathologic Correlation. AJR Am J Roentgenol 2015; 205:W478.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/121\" class=\"nounderline abstract_t\">Shen B, Remzi FH, Lavery IC, et al. A proposed classification of ileal pouch disorders and associated complications after restorative proctocolectomy. Clin Gastroenterol Hepatol 2008; 6:145.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/122\" class=\"nounderline abstract_t\">Wu B, Lian L, Li Y, et al. Clinical course of cuffitis in ulcerative colitis patients with restorative proctocolectomy and ileal pouch-anal anastomoses. Inflamm Bowel Dis 2013; 19:404.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/123\" class=\"nounderline abstract_t\">Shen B, Sanmiguel C, Bennett AE, et al. Irritable pouch syndrome is characterized by visceral hypersensitivity. Inflamm Bowel Dis 2011; 17:994.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/124\" class=\"nounderline abstract_t\">Shen B, Liu W, Remzi FH, et al. Enterochromaffin cell hyperplasia in irritable pouch syndrome. Am J Gastroenterol 2008; 103:2293.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/125\" class=\"nounderline abstract_t\">Hurst RD, Molinari M, Chung TP, et al. Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg 1996; 131:497.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/126\" class=\"nounderline abstract_t\">Okita Y, Araki T, Tanaka K, et al. Characteristics of extremely early-onset pouchitis after proctocolectomy with ileal pouch-anal anastomosis. J Gastrointest Surg 2013; 17:533.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/127\" class=\"nounderline abstract_t\">Mowschenson PM, Critchlow JF, Peppercorn MA. Ileoanal pouch operation: long-term outcome with or without diverting ileostomy. Arch Surg 2000; 135:463.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/128\" class=\"nounderline abstract_t\">Hurst RD, Chung TP, Rubin M, Michelassi F. The implications of acute pouchitis on the long-term functional results after restorative proctocolectomy. Inflamm Bowel Dis 1998; 4:280.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/129\" class=\"nounderline abstract_t\">Madiba TE, Bartolo DC. Pouchitis following restorative proctocolectomy for ulcerative colitis: incidence and therapeutic outcome. J R Coll Surg Edinb 2001; 46:334.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/130\" class=\"nounderline abstract_t\">Nicholls RJ. Review article: ulcerative colitis--surgical indications and treatment. Aliment Pharmacol Ther 2002; 16 Suppl 4:25.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/131\" class=\"nounderline abstract_t\">Liu ZX, Kiran RP, Bennett AE, et al. Diagnosis and management of dysplasia and cancer of the ileal pouch in patients with underlying inflammatory bowel disease. Cancer 2011; 117:3081.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/132\" class=\"nounderline abstract_t\">Kariv R, Remzi FH, Lian L, et al. Preoperative colorectal neoplasia increases risk for pouch neoplasia in patients with restorative proctocolectomy. Gastroenterology 2010; 139:806.</a></li><li><a href=\"https://www.uptodate.com/contents/pouchitis-epidemiology-clinical-manifestations-and-diagnosis/abstract/133\" class=\"nounderline abstract_t\">Derikx LA, Kievit W, Drenth JP, et al. Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease. Gastroenterology 2014; 146:119.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 4073 Version 18.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H1820268\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H1335092930\" id=\"outline-link-H1335092930\">DEFINITION</a><ul><li><a href=\"#H1335092780\" id=\"outline-link-H1335092780\">Classification</a></li></ul></li><li><a href=\"#H2\" id=\"outline-link-H2\">EPIDEMIOLOGY</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">PATHOGENESIS</a><ul><li><a href=\"#H525290177\" id=\"outline-link-H525290177\">Genetic factors</a></li><li><a href=\"#H525290250\" id=\"outline-link-H525290250\">Changes in gut microbiota</a></li><li><a href=\"#H525290635\" id=\"outline-link-H525290635\">Abnormal mucosal immunity</a></li></ul></li><li><a href=\"#H525291236\" id=\"outline-link-H525291236\">RISK FACTORS</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">CLINICAL MANIFESTATIONS</a><ul><li><a href=\"#H1755372193\" id=\"outline-link-H1755372193\">Clinical features</a></li><li><a href=\"#H1755372200\" id=\"outline-link-H1755372200\">Laboratory findings</a></li></ul></li><li><a href=\"#H1121783420\" id=\"outline-link-H1121783420\">EVALUATION</a><ul><li><a href=\"#H1755372101\" id=\"outline-link-H1755372101\">Diagnosis</a><ul><li><a href=\"#H242569\" id=\"outline-link-H242569\">- History</a></li><li><a href=\"#H242174\" id=\"outline-link-H242174\">- Laboratory studies</a></li><li><a href=\"#H1727626618\" id=\"outline-link-H1727626618\">- Endoscopy and biopsy</a></li><li><a href=\"#H1820101\" id=\"outline-link-H1820101\">- Additional evaluation</a></li></ul></li></ul></li><li><a href=\"#H525293002\" id=\"outline-link-H525293002\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H1835619414\" id=\"outline-link-H1835619414\">NATURAL HISTORY</a><ul><li><a href=\"#H10921945\" id=\"outline-link-H10921945\">Disease course</a></li><li><a href=\"#H10921951\" id=\"outline-link-H10921951\">Dysplasia or colorectal cancer</a></li></ul></li><li><a href=\"#H1820268\" id=\"outline-link-H1820268\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#H802830940\" id=\"outline-link-H802830940\">ACKNOWLEDGMENT</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"GAST/4073|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=GAST/93162\" class=\"graphic graphic_figure\">- Variation in the disease courses of pouchitis</a></li></ul></li><li><div id=\"GAST/4073|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=GAST/93165\" class=\"graphic graphic_picture\">- Histology of pouch mucosal</a></li><li><a href=\"image.htm?imageKey=GAST/93166\" class=\"graphic graphic_picture\">- Endoscopy of the J pouch</a></li><li><a href=\"image.htm?imageKey=GAST/93161\" class=\"graphic graphic_picture\">- Endoscopic spectrum of pouchitis and pouch disorders</a></li></ul></li><li><div id=\"GAST/4073|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=GAST/94138\" class=\"graphic graphic_table\">- Pouchitis Disease Activity Index</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-familial-adenomatous-polyposis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of familial adenomatous polyposis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-of-celiac-disease-in-adults\" class=\"medical medical_review\">Diagnosis of celiac disease in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diversion-colitis\" class=\"medical medical_review\">Diversion colitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-igg4-related-disease\" class=\"medical medical_review\">Overview of IgG4-related disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-diagnostic-tests-for-cytomegalovirus-infection\" class=\"medical medical_review\">Overview of diagnostic tests for cytomegalovirus infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pouchitis-management\" class=\"medical medical_review\">Pouchitis: Management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=primary-sclerosing-cholangitis-in-adults-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Primary sclerosing cholangitis in adults: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=primary-sclerosing-cholangitis-inflammatory-bowel-disease-and-colorectal-cancer\" class=\"medical medical_review\">Primary sclerosing cholangitis: Inflammatory bowel disease and colorectal cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=restorative-proctocolectomy-with-ileal-pouch-anal-anastomosis-laparoscopic-approach\" class=\"medical medical_review\">Restorative proctocolectomy with ileal pouch-anal anastomosis: Laparoscopic approach</a></li></ul></div></div>","javascript":null}